Non‐myeloablative allogeneic HSCT in adult patients with sickle cell disease: Multiple take‐home points from the Saudi Arabia experience

Documenti analoghi

• Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry
  di: Franklin Njoku, et al.
  Pubblicazione: (2024)
• The spectrum of sickle cell disease
  di: Barbara J. Bain
  Pubblicazione: (2024)
• Effect of voxelotor on cerebral perfusion and cerebral oxygen metabolism and cardiac stress in adult patients with sickle cell disease
  di: Kadère Konté, et al.
  Pubblicazione: (2024)
• GLP‐1 agonists and SGLT‐2 inhibitors in adults with sickle cell disease
  di: Ryan Sun, et al.
  Pubblicazione: (2024)
• Emergency department intravenous fluid resuscitation and renal outcomes among adults with sickle cell disease
  di: Marcus A. Carden, et al.
  Pubblicazione: (2024)